Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
8/29/24 18:43 | 8/27/24 | SPRO | Health | Drug | Pharmaceutical Preparations | Mahadevia Ankit | MA | D | 3 | S | -107 | 1.36 | 0 | -79 | 789 | D | ||||||||||||||||
8/29/24 18:42 | 8/27/24 | SPRO | Health | Drug | Pharmaceutical Preparations | Keutzer Timothy | MA | O | COO | 3 | S | -47 | 1.35 | 0 | -35 | 534 | D | |||||||||||||||
8/29/24 18:36 | 8/27/24 | SPRO | Health | Drug | Pharmaceutical Preparations | Shukla Sath | MA | O | CEO,P | 4 | S.m | -162 | 1.38 | 0 | -117 | 1,176 | D | |||||||||||||||
2/5/24 20:48 | 2/2/24 | SPRO | Health | Drug | Pharmaceutical Preparations | Joseph Tamara L | MA | O | GC | 2 | S | -45 | 1.36 | 0 | -33 | 532 | D | |||||||||||||||
2/5/24 20:45 | 2/2/24 | SPRO | Health | Drug | Pharmaceutical Preparations | Hamed Kamal | MA | O | Chief Me | 2 | S | -89 | 1.31 | 0 | -68 | 788 | D |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |